| Primary |
| Hypertension |
42.6% |
| Arrhythmia |
9.8% |
| Blood Cholesterol Increased |
6.8% |
| Product Used For Unknown Indication |
4.1% |
| Hypercholesterolaemia |
3.4% |
| Atrial Fibrillation |
3.0% |
| Coronary Artery Occlusion |
3.0% |
| Diabetes Mellitus |
3.0% |
| Myocardial Infarction |
2.7% |
| Thrombosis Prophylaxis |
2.7% |
| Blood Pressure Abnormal |
2.4% |
| Depression |
2.4% |
| Tachycardia |
2.4% |
| Anticoagulant Therapy |
2.0% |
| Ischaemic Heart Disease Prophylaxis |
2.0% |
| Blood Cholesterol Abnormal |
1.7% |
| Cardiac Disorder |
1.7% |
| Osteoarthritis |
1.7% |
| Anxiety |
1.4% |
| Cardiac Failure |
1.4% |
|
| Off Label Use |
18.1% |
| Coronary Artery Occlusion |
12.5% |
| Weight Decreased |
8.3% |
| Pain In Extremity |
6.9% |
| Weight Increased |
6.9% |
| Myocardial Infarction |
5.6% |
| Nausea |
4.2% |
| Vision Blurred |
4.2% |
| Aortic Occlusion |
2.8% |
| Blood Pressure Increased |
2.8% |
| Chest Pain |
2.8% |
| Drug Intolerance |
2.8% |
| Hypotension |
2.8% |
| Hypothyroidism |
2.8% |
| Malaise |
2.8% |
| Somnolence |
2.8% |
| Syncope |
2.8% |
| Tinnitus |
2.8% |
| Torsade De Pointes |
2.8% |
| Tremor |
2.8% |
|
| Secondary |
| Hypertension |
37.1% |
| Arrhythmia |
12.9% |
| Depression |
6.9% |
| Tachycardia |
4.3% |
| Blood Cholesterol Increased |
4.2% |
| American Trypanosomiasis |
4.0% |
| Product Used For Unknown Indication |
3.5% |
| Hypercholesterolaemia |
3.4% |
| Diabetes Mellitus |
3.0% |
| Gastrooesophageal Reflux Disease |
2.9% |
| Cardiac Disorder |
2.3% |
| Dyspepsia |
2.2% |
| Anticoagulant Therapy |
2.1% |
| Heart Rate Abnormal |
1.8% |
| Myocardial Infarction |
1.8% |
| Thrombosis Prophylaxis |
1.7% |
| Mitral Valve Prolapse |
1.6% |
| Atrial Fibrillation |
1.4% |
| Coronary Artery Disease |
1.4% |
| Gastritis |
1.4% |
|
| Off Label Use |
24.6% |
| Weight Increased |
10.8% |
| Tachycardia |
7.7% |
| Thrombosis |
5.4% |
| Tinnitus |
5.4% |
| Weight Decreased |
5.4% |
| Coronary Artery Occlusion |
4.6% |
| Myocardial Infarction |
4.6% |
| Drug Intolerance |
3.1% |
| Hypertension |
3.1% |
| Mitral Valve Disease |
3.1% |
| Myalgia |
3.1% |
| Venous Occlusion |
3.1% |
| Heart Rate Increased |
2.3% |
| Insomnia |
2.3% |
| Intentional Drug Misuse |
2.3% |
| Ischaemia |
2.3% |
| Pain In Extremity |
2.3% |
| Panic Disorder |
2.3% |
| Somnolence |
2.3% |
|
| Concomitant |
| Hypertension |
22.1% |
| Product Used For Unknown Indication |
18.6% |
| Cardiac Disorder |
7.1% |
| Rheumatoid Arthritis |
5.2% |
| Cardiac Failure |
4.8% |
| Drug Use For Unknown Indication |
4.6% |
| Diabetes Mellitus |
3.8% |
| Acute Myocardial Infarction |
3.7% |
| Anticoagulant Therapy |
3.4% |
| Blood Cholesterol |
3.3% |
| Prophylaxis |
3.3% |
| Arrhythmia |
3.2% |
| Osteoporosis |
2.8% |
| Atrial Fibrillation |
2.4% |
| Depression |
2.4% |
| Type 2 Diabetes Mellitus |
2.4% |
| Dyspnoea |
1.9% |
| Pain |
1.9% |
| Blood Cholesterol Increased |
1.8% |
| Blood Pressure |
1.5% |
|
| Weight Decreased |
10.6% |
| Vomiting |
9.3% |
| Weight Increased |
8.7% |
| Urinary Tract Infection |
7.5% |
| Infarction |
6.2% |
| Tachycardia |
5.6% |
| Pain |
5.0% |
| Renal Impairment |
4.3% |
| Thrombosis |
4.3% |
| Tremor |
4.3% |
| Nephrogenic Systemic Fibrosis |
3.7% |
| Pruritus |
3.7% |
| Syncope |
3.7% |
| Urinary Retention |
3.7% |
| Venous Occlusion |
3.7% |
| Hemiplegia |
3.1% |
| Myocardial Infarction |
3.1% |
| Pain In Extremity |
3.1% |
| Pleural Effusion |
3.1% |
| Pyrexia |
3.1% |
|
| Interacting |
| Drug Use For Unknown Indication |
100.0% |
|
| Torsade De Pointes |
100.0% |
|
